Zinereo Pharma participated last February in Probiota Dublin 2026, one of the leading international events in the field of microbiome, probiotics, and health. The event brought together experts, companies, and industry leaders to share scientific advances and explore the trends shaping the future of the sector globally.

During the event, we actively participated in sessions focused on microbiome science, regulatory developments, and market evolution.

The meeting highlighted the sustained growth of the sector, the expanding applications of the microbiome, and its global expansion, emphasizing the importance of evidence-based innovation, responsible development, and international collaboration.

Zinereo Pharma’s participation in Probiota reinforces its positioning within the global microbiome ecosystem and its commitment to developing innovative, science-based solutions.

In the pictures, Ana Nunes – Business Unit Director, and Esther Dagá – Regulatory Affairs and Training Manager